Fundraising FoxMarrow Access Technologies
Eden Prairie, US · Founded 2017 · Minnesota corporation
Find your way into Marrow Access Technologies
Sign up to see every warm intro you have to Marrow Access Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Marrow Access Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JK
Jason KohExecutive
JS
Joseph SaladinoExecutive
Board
PV
Paul VerrastroBoard director
DF
Dan FisherBoard director
KF
Kevin FoleyBoard director
JC
Jim CloarBoard director
Reported raises · per SEC filings
Form D private placements$996.4K disclosed across 4 rounds · 2018–2026
▶$100KraisedApr 2026 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedApr 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jason KohExecutive Officer, Director
- Paul VerrastroDirector
- Dan FisherDirector
- Joseph SaladinoExecutive Officer, Director
- Kevin FoleyDirector
- Jim CloarDirector
- Offering amount
- $300K
- Amount sold
- $100K
- Minimum investment
- $25K
- Proceeds to insiders
- $120K
- First sale
- Mar 2026
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$241.4KraisedJun 2024 · 2 investors · Other Health CareRule 506(b)
▶$241.4KraisedJun 2024 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph SaladinoExecutive Officer, Director
- Jim CloarDirector
- Paul VerrastroDirector
- Dan FisherExecutive Officer, Director
- Jason KohExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $241.4K
- Minimum investment
- $100K
- Proceeds to insiders
- $100K
- First sale
- Mar 2024
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$140KraisedJun 2023 · 6 investors · Other Health CareRule 506(b)
▶$140KraisedJun 2023 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joseph SaladinoDirector
- Kevin FoleyDirector
- Joseph SaladinoExecutive Officer, Director
- Dan FisherExecutive Officer, Director
- Jason KohExecutive Officer, Director
- Paul VerrastroDirector
- Offering amount
- $2M
- Amount sold
- $140K
- Minimum investment
- $10K
- Proceeds to insiders
- $150K
- First sale
- Feb 2023
- Incorporated
- Corporation, Minnesota
- Federal exemptions
- 06b
▶$515KraisedJun 2020 · 18 investors · Other Health CareRule 506(b)
▶$515KraisedJun 2020 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- JASON KOHExecutive Officer
- JOSEPH SALADINOExecutive Officer, Director
- DAN FISHERExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $515K
- First sale
- Oct 2018
- Incorporated
- Corporation, Minnesota, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Marrow Access Technologies raised?
- Marrow Access Technologies has disclosed $996.4K raised across 4 rounds.
- Where is Marrow Access Technologies headquartered?
- Marrow Access Technologies is headquartered in Eden Prairie, US.